The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
The Labour leader said he doesn't believe culture should be just for the elites.
Rain will spread into southern and central England but elsewhere will remain dry with warm sunny spells.
French mayors have been told they must not ban the 'Burkini' in their towns as a court ruling suspends the ban.